Open Access
Add to BibSonomyAbstract
Optical metabolic imaging (OMI) quantifies the fluorescence intensities and lifetimes of NADH and FAD using two-photon microscopy. OMI allows for cells to be monitored within tumors, to design effective cancer therapies and personalize cancer treatment.
© 2016 Optical Society of America
PDF Article | Presentation VideoMore Like This
Fluorescence lifetime imaging of cellular-level metabolic heterogeneity in cancer
Melissa C. Skala
CL_2_3 The European Conference on Lasers and Electro-Optics (CLEO/Europe) 2015
Quantitative Autofluorescence Imaging Measures Early Response to Head and Neck Cancer Treatment In Vivo
Amy T. Shah, Alex J. Walsh, Paula R. Pohlmann, and Melissa C. Skala
FM4F.4 Frontiers in Optics (FiO) 2014
Autofluorescence Imaging Resolves Early Cancer Treatment Response In Vivo
Alex Walsh, Rebecca S. Cook, H. Charles Manning, Donna J. Hicks, Alec Lafontant, Carlos L. Arteaga, and Melissa C. Skala
MT3C.5 Optical Molecular Probes, Imaging and Drug Delivery (OMP) 2013